Decisiondx®-scc significantly improves prediction accuracy of metastatic events after mohs surgery in new study of patients with high-risk cutaneous squamous cell carcinoma tumors of the head and neck

Friendswood, texas--(business wire)---- $cstl #acms--castle biosciences will share new data supporting the utility of its decisiondx®-scc test at the acms annual meeting in phoenix.

CSTL Ratings Summary

CSTL Quant Ranking